HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Flowcytometric assessment of fetomaternal hemorrhage during external cephalic version at term.

Abstract
External cephalic version (ECV) at term is a safe procedure and reduces the incidence of cesarean sections for breech presentation. One of the known complications, however, is an ECV-related disruption of the placental barrier and a subsequent transfusion of fetal blood into maternal circulation. While the incidence of ECV-related fetomaternal hemorrhage (FMH) has been determined recently in a large trial using a manual Kleihauer-Betke test (KBT), questions remain on the amount of ECV-related FMH. KBT, which detects fetal red blood cells (RBC) on the basis of acidic resistance of fetal hemoglobin (HbF), is known to be a sensitive test, yet prone to procedural errors limiting its accuracy in quantifying FMH. In this study we investigated 50 patients for FMH before and after ECV, using a dual-color flow cytometric test kit with a lower limit of quantification of 0.05% fetal RBC in maternal peripheral blood. Three patients had a quantifiable increase of fetal RBC detected after ECV (0.06%; 0.08%; 0.1%). None of these subtle increments was predictable by ECV-related clinical parameters or translated into fetal compromise. Using a sensitive and accurate flow cytometric test method, our data provide further assurance to mothers on the safety of ECV at term.
AuthorsChristoph Scholz, Andrea Kachler, Christine Hermann, Tobias Weissenbacher, Bettina Toth, Klaus Friese, Franz Kainer
JournalJournal of perinatal medicine (J Perinat Med) Vol. 37 Issue 4 Pg. 334-7 ( 2009) ISSN: 0300-5577 [Print] Germany
PMID19290855 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Erythrocyte Count
  • Female
  • Fetomaternal Transfusion (etiology)
  • Flow Cytometry
  • Humans
  • Pregnancy
  • Prospective Studies
  • Version, Fetal (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: